Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Frederick H Waddell is Director at IBM. OQRO lists 3 transactions filed with the SEC under this name, the latest on May 12, 2026, each linked to the official Form 4.
Director
Disclosures on record
3
Companies involved
2
As of the latest filing on , Frederick H Waddell reported holding 30,076 shares of AbbVie (ABBV), worth about $8.6M at the last close of $286 (Nov 18, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| AbbVie ABBV | 30,076 | 30K direct | $286 | $8.6M | May 8, 2026 |
Is this Frederick H Waddell’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
AbbVieABBV
May 8, 20261,118disclosed May 12
DetailsOfficial recordIBM
2 disclosures · Jan 2026 – Apr 2026
Mar 31, 2026403disclosed Apr 2
Dec 31, 2025330disclosed Jan 3
DetailsOfficial recordFrederick H Waddell bought shares on the open market in 2013, 2018 and 2020, and has not bought since 2020 across 3 companies. Sales in 9 of the 21 years since 2006.
Frederick H Waddell reported 5 open-market purchases and 101 sales since 2006; purchases in 3 different years, most recently 2020.
| Year | Bought | Sold |
|---|---|---|
| 2020 | $108K1×1 trade | — |
| 2018 | $349K3×3 trades | — |
| 2017 | — | $49.2M6×6 trades |
| 2016 | — | $42.2M9×9 trades |
| 2015 | — | $6.44M5×5 trades |
| 2014 | — | $9.18M4×4 trades |
| 2013 | $74K1×1 trade | $4.95M3×3 trades |
| 2010 | — | $135K1×1 trade |
| 2008 | — | $2.29M1×1 trade |
| 2007 | — | $1.75M65×65 trades |
| 2006 | — | $811K7×7 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated May 8, 2026, Frederick H Waddell reported holding 30,076 shares of AbbVie (ABBV). At the last close of $286 on Nov 18, 2026, that is about $8.6M. This is the stake disclosed in filings, not a net worth.
No public filing gives Frederick H Waddell's net worth. What SEC Form 4 shows is the stock stake: 30,076 shares of AbbVie (ABBV), about $8.6M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Frederick H Waddell bought shares on the open market in 2013, 2018 and 2020, and has not bought since 2020 across 3 companies. Sales in 9 of the 21 years since 2006.
In SEC filings since 2006: the latest open-market purchase is from 2020; the latest open-market sale is from 2017.
3 companies: IBM (IBM, 2018–2020), Northern Trust (NTRS, 2006–2017), AbbVie (ABBV, 2013).
Frederick H Waddell reported 0 open-market purchases and 101 sales here, 2006 to 2017.
Frederick H Waddell reported 4 open-market purchases and 0 sales here, 2018 to 2020.
Frederick H Waddell reported 1 open-market purchase and 0 sales here, 2013.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.